Home
About
Why D4DPR?
Strategic Vision
Platform of Regulations
Leadership
D4DPR Experts
D4DPR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Resources
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Expert Testimony
Doctors for Drug Policy Reform
Expert Testimony
D4DPR Updates
D4DPR requests a hearing with the DEA in the matter of “Schedules of Controlled Substances: Rescheduling of Marijuana”
Medical (cannabis)
7/9/24
Expert Testimony
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
Adult Use (cannabis)
Bryon Adinoff, MD
11/16/23
Expert Testimony
Opposing Maryland’s Cannabis-induced Psychosis and THC Concentration Limit (HB 23-1147)
Medical (cannabis)
Bryon Adinoff, MD
3/1/23
Expert Testimony
Supporting Hawaii’s Adult Use Cannabis Program (SB375)
Adult Use (cannabis)
Bryon Adinoff, MD
2/17/23
Expert Testimony
Supporting Colorado’s Access to Medical Marijuana (SB 081)
Medical (cannabis)
Bryon Adinoff, MD
2/17/23
Expert Testimony
Supporting Maryland’s Adult Use Cannabis Program (HB556)
Medical (cannabis)
Deondra Asike
2/16/23
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 23-2)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
1/24/23
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 560)
Medical (cannabis)
Bryon Adinoff, MD
6/29/22
Expert Testimony
Supporting Override of Delaware’s Governor Veto of Adult Use Cannabis Program (HB 371)
Adult Use (cannabis)
6/2/22
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
2/24/22
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 305)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
1/26/22
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
10/1/21
Expert Testimony
Testimony to New Jersey’s Cannabis Regulatory Commission
Regulatory (cannabis)
6/2/21
Expert Testimony
Opposing Colorado’s Cannabis Potency Cap (HB 21-1317)
Regulatory (cannabis)
Bryon Adinoff, MD
5/18/21
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 46)
Medical (cannabis)
Bryon Adinoff, MD
4/26/21
Expert Testimony
Supporting Texas’ Penalty Reduction for Cannabis Possession (HB 3772)
Penalty Reduction (cannabis)
Bryon Adinoff, MD
4/20/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
Adult Use (cannabis)
Bryon Adinoff, MD
3/24/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
3/24/21
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Regulatory (cannabis)
Hugh Blumenfeld, MD, PhD
3/1/21
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Adult Use (cannabis)
Bryon Adinoff, MD
2/25/21
Expert Testimony
Supporting New York’s Adult Use Cannabis Program (Marijuana Regulation & Taxation Act)
Medical (cannabis)
Tanya Adams, DO
2/23/21
Expert Testimony
Supporting New Jersey’s Adult Use Cannabis Program (AB 1898)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
2/22/21
Expert Testimony
Supporting Virginia’s Adult Use Cannabis Program (HB 2312 and SB 1406)
Adult Use (cannabis)
Bryon Adinoff, MD
1/31/21
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
Adult Use (cannabis)
1/1/21
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
Regulatory (cannabis)
1/1/21
Expert Testimony
Supporting Sound Regulatory Standards for the Medical Cannabis Program in New Jersey (A21)
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
11/20/20
Expert Testimony
Supporting Social Justice and Optimal Labeling for Cannabis Programs in New Jersey
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
11/10/20
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 16)
Adult Use (cannabis)
Bryon Adinoff, MD
3/3/20
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 16)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
3/3/20
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 165)
Medical (cannabis)
1/1/20
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 165)
Medical (cannabis)
Donald O. Lyman, MD, DTPH
1/1/20
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 165)
Medical (cannabis)
Genester Wilson-King, MD, FACOG
1/1/20
Expert Testimony
Supporting New Jersey’s Adult Use Cannabis Program (ACR 840)
Monica Taing, PharmD
12/12/19
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 366)
Medical (cannabis)
Bryon Adinoff, MD
10/23/19
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 366)
Medical (cannabis)
Wendy Askew, MD
10/23/19
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 366)
Medical (cannabis)
Rachel Knox, MD
10/23/19
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 366)
Medical (cannabis)
Genester Wilson-King, MD, FACOG
10/23/19
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 366)
Medical (cannabis)
Donald O. Lyman, MD, DTPH
10/23/19
Expert Testimony
Supporting Cannabis Legalization in the United States - Invited D4DPR Testimony in the House of Representatives
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
7/10/19
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 110)
Adult Use (cannabis)
Bryon Adinoff, MD
6/5/19
Expert Testimony
Recommendations for Amendments to Colorado’s Medical Marijuana Code (SB 218)
Medical (cannabis)
Bryon Adinoff, MD
5/10/19
Expert Testimony
Supporting Regulatory Changes to Vermont’s Adult Use Cannabis Program (SB 54)
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
4/30/19
Expert Testimony
Supporting South Carolina’s Medical Cannabis Program (S 366)
Medical (cannabis)
Bryon Adinoff, MD
4/6/19
Expert Testimony
Supporting New Jersey’s Adult Use Cannabis Program (SB 2703)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
3/19/19
Expert Testimony
Supporting Expansion of Texas’ Medical Cannabis Program (HB 1365)
Medical (cannabis)
Bryon Adinoff, MD
3/16/19
Expert Testimony
Supporting Texas’ Penalty Reduction for Cannabis Possession (HB 63)
Penalty Reduction (cannabis)
Bryon Adinoff, MD
3/4/19
Expert Testimony
Supporting Vermont's Adult Use Regulation (SB 54)
David L. Nathan, MD, DFAPA
2/1/19
Expert Testimony
Supporting New York Adult Use
Adult Use (cannabis)
12/1/18
Expert Testimony
Supporting New Jersey’s Adult Use Cannabis Program (SB 2703)
Adult Use (cannabis)
11/1/18
Expert Testimony
Supporting New Jersey's CSA Reclassification of Cannabis
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
4/25/18
Expert Testimony
U.S. FDA Cannabis Scheduling
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
4/23/18
Expert Testimony
Supporting Optimal Regulation of Medical Cannabis in New Jersey
David L. Nathan, MD, DFAPA
3/6/18
Expert Testimony
Supporting Illinois Adult Use Cannabis Program (SB 316, HB 2353)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
1/23/18
Expert Testimony
Supporting New Jersey’s Adult Use Cannabis Program
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
6/19/17
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 110)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
5/11/17
Expert Testimony
Supporting Texas Medical Cannabis Program Expansion/Penalty Elimination (HB 2107)
Penalty Reduction (cannabis)
Bryon Adinoff, MD
5/3/17
Expert Testimony
Supporting California Testing and Labeling of Adult Use Cannabis (AB 1606)
Regulatory (cannabis)
D4DPR
4/14/17
Expert Testimony
Supporting Vermont Penalty Reduction for Cannabis Possession and Cultivation (H 170)
Adult Use (cannabis)
Bryon Adinoff, MD
4/12/17
Expert Testimony
Supporting Rhode Island Adult Use Cannabis Regulation to House Judiciary (HB 5555)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
4/12/17
Expert Testimony
Supporting Texas Cannabis Possession Penalty Reduction/Elimination (HB 81)
Penalty Reduction (cannabis)
Bryon Adinoff, MD
3/14/17
Expert Testimony
Supporting Adult Use Cannabis to New Jersey Senate Judiciary
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
11/17/15
Browse by Location
Alabama
California
Colorado
Connecticut
Delaware
Federal
Hawaii
Illinois
International
Kansas
Maryland
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia
Browse by Topic
Opioids
Harm Reduction
Psychedelics
Penalty Reduction (cannabis)
Regulatory (cannabis)
Medical (cannabis)
Adult Use (cannabis)
Support Our Mission
DONATE
JOIN